Webinar Series: Data Science in Action in Response to the Outbreak of COVID19

June 12, 2020 11 am (ET)

Statistics and Modeling in Response to COVID-19 at NIAID

Speaker

Dr. Dean Follmann, Chief of the Biostatistics Research Branch at the National Institute of Allergy and Infectious Diseases (NIAID)

Abstract

The COVID-19 pandemic is an enormous public health challenge which requires an extraordinary response. At the National Institute of Allergy and Infectious Diseases, statisticians have been deeply involved in crafting and executing research to better understand, treat and prevent COVID-19. This talk will focus on the statistical aspects of different current projects including design of vaccine trials, issues in constructing running platform treatment trials, epidemiologic modeling, and the role of the immune response in modulating vaccine efficacy.

 


Agenda

About the Speaker

Dean Follmann is Chief of the Biostatistics Research Branch at the National Institute of Allergy and Infectious Diseases (NIAID), a role he has held for the past 16 years. He has authored or co-authored more than 250 peer-reviewed research articles and received numerous awards, including the Department of Health and Human Services Secretary’s Award for Distinguished Service, the Best Paper in Biometrics 2009, and is an elected Fellow of the American Statistical Association in 2003. He serves on committees and advisory boards for the US Food and Drug Administration, the National Institutes of Health, and academic departments. Current research interests focus on statistical methods related to vaccinology.

Event Type

Host

ASA Section on Statistical Learning and Data Science
Journal of Data Science

Sponsor

ASA Section on Statistical Computing
ASA Section on Statistics in Epidemiology
ASA Section on Statistical Graphics
National Institute of Statistical Science
New England Statistical Society
Statistical Data Science Lab at UConn

Location

Online Webinar
Dr. Dean Follmann, Chief of the Biostatistics Research Branch at the National Institute of Allergy and Infectious Diseases (NIAID)